Transcatheter Cardiovascular Therapeutics (TCT)

The Transcatheter Cardiovascular Therapeutics (TCT) conference is the Cardiovascular Research Foundation's (CRF) annual scientific symposium and the largest conference focused on interventional cardiovascular medicine. TCT includes seminars on all areas of intervention cardiology, structural heart, vascular in interventions, peripheral artery disease, and other procedures in the cath lab.

heart.png

TAVR more cost-effective than surgery for low-risk patients, new 2-year study confirms

The analysis, presented at TCT 2021, examined total costs after two years for more than 900 patients who underwent TAVR or SAVR.

November 5, 2021

Patients amenable to interventional procedure for lowering blood pressure

The analysis, presented at TCT 2021, included input from 400 patients with high blood pressure. 

November 4, 2021
elderly patient mask covid

CABG still the ‘treatment of choice’ for patients with complex three-vessel CAD

The findings were presented at TCT 2021 and published in the New England Journal of Medicine.

November 4, 2021
telehealth.jpg

TCT 2021 now offering free virtual attendance

The three-day event is sponsored by the Cardiovascular Research Foundation.

October 26, 2021
Doctor patient

Confirmed: Watchman FLX LAAC device safe for nonvalvular AFib patients

New two-year findings, presented at TVT 2021, suggest that the Watchman FLX device is a safe alternative to long-term oral anticoagulation therapy.

July 23, 2021

MitraClip an effective bridge strategy for advanced heart failure patients waiting for a heart transplant

The findings were presented Friday, Oct. 16, at TCT Connect 2020.

October 16, 2020

Intravascular lithotripsy ‘safely and effectively’ facilitates stent delivery for CAD patients

The findings were presented Thursday, Oct. 15, at TCT Connect 2020.

October 15, 2020
Driven by its strategic goal to advance equity in the U.S. healthcare innovation sector, the American Medical Association (AMA) recently announced an initiative that supports leading industry stakeholders in committing to equitable health innovation opportunities targeted to improving health outcomes in historically marginalized communities. #Healthdisparities 

Bivalirudin bests heparin for treating heart attack patients undergoing PCI

The findings were presented Wednesday, Oct. 14, during TCT Connect 2020. 

October 14, 2020

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup